JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M001168200 on May 12, 2000

J. Biol. Chem., Vol. 275, Issue 32, 24333-24340, August 11, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/32/24333    most recent
M001168200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Das, A. K.
Right arrow Articles by Hajra, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Das, A. K.
Right arrow Articles by Hajra, A. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular Cloning and Expression of Mammalian Peroxisomal trans-2-Enoyl-coenzyme A Reductase cDNAs*

Arun K. Das, Michael D. Uhler, and Amiya K. HajraDagger

From the Mental Health Research Institute and Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan 48104-1687

Received for publication, February 10, 2000, and in revised form, April 20, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Chain elongation of fatty acids is an important cellular process and is believed to occur in the endoplasmic reticulum of all eukaroytic cells. Herein we describe the cloning and characterization of a peroxisomal NADPH-specific trans-2-enoyl-CoA reductase, the key enzyme for a proposed peroxisomal chain elongation pathway. The reductase was solubilized and partially purified from guinea pig liver peroxisomes by affinity chromatography. On SDS-polyacrylamide gel electrophoresis, a 40-kDa band was identified as the enzyme, and its partial amino acid sequence (27 amino acids) was determined. A full-length cDNA for the reductase was cloned from a guinea pig liver cDNA library. The open reading frame of this nucleotide sequence encodes a 302-amino acid polypeptide with a calculated molecular mass of 32.5 kDa. Full-length mouse and human cDNA clones encoding homologous proteins have also been isolated. All of these translated polypeptides have the type I peroxisomal targeting signal, AKL, at the carboxyl terminus. The identity of the cloned enoyl-CoA reductase cDNAs was confirmed by expressing the guinea pig and human cDNAs in Escherichia coli. The His-tagged recombinant enzymes were found to have very high NADPH-specific 2-enoyl-CoA reductase activity with similar properties and specificity as the liver peroxisomal reductase. Both the natural and the recombinant enzyme catalyze the reduction of trans-2-enoyl-CoAs of varying chain lengths from 6:1 to 16:1, having maximum activity with 10:1 CoA. Northern blot analysis demonstrated that a single transcript of 1.3 kilobases is present in most mouse tissues, with particularly high concentrations in liver and kidney.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In mammalian cells, the fatty acid chain elongation system has been shown to be present in both endoplasmic reticulum (ER)1 and mitochondria (1). The ER pathway is similar to the fatty acid synthesis system. In this multistep process, malonyl-CoA first condenses with acyl-CoA to form a beta -keto acyl-CoA with two additional carbons with the release of CO2. The beta -keto acyl-CoA then undergoes reduction of the ketone group followed by dehydration to form a 2-enoyl-CoA, which is then reduced by NADH or NADPH to form the longer (+2C) acyl-CoA. Chain elongation and other biotransformation of fatty acids have been shown to occur primarily in the ER (1, 2). The mitochondrial chain elongation system is a reversal of the fatty acid beta -oxidation system; thus, acetyl-CoA, instead of malonyl-CoA, is used for the condensation reaction, and the resulting beta -keto acyl-CoA undergoes the same series of reactions as described above (3). The physiological function of the mitochondrial chain elongation system is not clear (4).

Contradictory findings have been reported regarding the presence of another cellular fatty acid chain elongation system in mammalian peroxisomes. Nagi et al. (5) initially reported the absence of an elongation system in rat liver peroxisomes. However, Horie et al. (6) later provided good evidence for the presence of an active peroxisomal chain elongation system in rat liver. This peroxisomal system was shown to be similar to the mitochondrial system in that acetyl-CoA is used as the carbon donor for chain elongation. In both, all of the chain elongation reactions are apparently catalyzed by the fatty acid beta -oxidation pathway enzymes in the reverse directions except for the last step (i.e. the reduction of the 2-enoyl-CoA). This is because in the beta -oxidation pathway the initial oxidation of acyl-CoAs to 2-enoyl-CoAs is an irreversible step catalyzed by either acyl-CoA dehydrogenase (mitochondria) or oxidase (peroxisomes). Therefore, a separate 2-enoyl-CoA reductase is necessary for the reduction of the double bond at C-2 at the last step of elongation. Mitochondria have been shown to contain such a specific 2-enoyl-CoA reductase, which has been purified to homogeneity as a 35.5-kDa protein (4). This purified enzyme only utilized NADPH as the coenzyme. Horie et al. (6) provided good evidence for the presence of a similar NADPH-linked enoyl-CoA reductase in rat liver peroxisomes, although the enzyme was not solubilized or purified.

During the course of purification of guinea pig liver peroxisomal acyldihydroxyacetone phosphate (DHAP) reductase (7), a contaminating 40-kDa protein was found to be associated with the reductase. This protein was found to bind to the NADPH affinity column along with the acyl-DHAP reductase. We report here that this protein is a 2-enoyl-CoA reductase. From its partial amino acid sequence information, we have cloned the cDNA of this guinea pig liver protein and also the corresponding mouse and human cDNAs. The guinea pig cDNA was expressed in Escherichia coli, and the recombinant protein has been found to have high trans-2-enoyl-CoA reductase activity with NADPH as the reductant.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Synthesis of trans-2-Enoyl-CoAs-- trans-2-Hexenoic and octenoic acids were obtained from Aldrich. trans-2-Decenoic, 2-dodecenoic, and 2-hexadecenoic acids were kind gifts from Dr. Shuichi Horie (Teikyo University, Kanagawa, Japan). trans-2-Tetradecenoic acid was synthesized by condensing dodecyl aldehyde (Aldrich) with malonic acid in pyridine followed by decarboxylation as described by Lauer et al. (8). All-trans-2,4-decadienoic acid was prepared by oxidizing 2-trans,4-trans-decadienal (Aldrich) by Ag2O as described (9). The CoA derivatives of all these fatty acids were prepared by first converting them to acyl chlorides, followed by condensing the acyl chlorides with CoASH (1.1:1.0 molar ratio) in carbonate buffer at pH 8.5 as described previously (10). The 12:1, 14:1, and 16:1 CoA were purified by perchloric acid precipitation followed by acetone and ether washings (10). The crude 6:1, 8:1, and 10:1 CoA preparations were purified by acidification to pH 3 followed by extraction with diethyl ether to remove the free fatty acids. The pH of the aqueous layers was then adjusted to 6.0, and the enoyl-CoA was lyophilized. The 10:1 CoA was further purified by hydrophobic chromatography on an octadecyl-silica column. The decenoyl-CoA dissolved in 0.1 M sodium phosphate buffer (pH 6.0) was loaded onto a 2-ml C-18 SPE-Bakerbond cartridge (J.T. Baker), and after washing the column with 8 ml of the same buffer, the enoyl-CoA was eluted with 4 ml of methanol. The methanol was removed at room temperature by blowing a stream of N2, and the residue was dissolved in 0.05 M sodium phosphate buffer (pH 6.0). The recovery of the enoyl-CoA was 80%. Thin-layer chromatography of the acyl-CoAs on Silica Gel 60 (Merck) using butanol/acetic acid/water (50:20:30) as the mobile phase (10) showed that the acyl-CoAs (Rf = 0.45) were pure, with only traces of free CoA (Rf = 0.16) and no free fatty acids (Rf = 0.82) present as contaminant. The enoyl-CoAs were also characterized by their spectral properties (10, 11). Crotonyl-(trans-4:1Delta 2)-CoA was purchased from Sigma. The concentrations of the acyl-CoAs were determined by measuring the amount of CoASH released after alkaline hydrolysis, with 5,5'-dithio-bis(2-nitrobenzoic acid) (12).

Assay of Enoyl-CoA Reductase-- Spectrophotometric and radiometric assays were used to measure the enzyme activity. In the radiometric assay, the incubation mixture contained phosphate buffer (50 mM, pH 7.4), S-[4-3H]NADPH (70 µM, 8000 dpm/nmol), fatty acid-poor bovine serum albumin (2 mg/ml), enoyl-CoAs (30-40 µM), and enzyme protein in a total volume of 0.3 ml. After incubation at 37 °C for 5 min, the reactions were stopped by adding 50 µl of 1 N NaOH. The mixture was incubated at 37 °C for an additional 10 min to hydrolyze all acyl-CoAs and then acidified by adding 10 µl of 6 N HCl followed by the addition of 0.75 ml of 2 M KCl containing 0.05 M H3PO4. The free fatty acids were extracted from the mixture with 1 ml of toluene, and the 3H radioactivity in an aliquot of the toluene layer was determined by liquid scintillation spectrometry.

For the spectrophotometric assay, the incubation mixture was the same as above except that nonradioactive NADPH (0.l mM) was used instead of the [3H]NADPH. The time course of oxidation of NADPH was monitored at 340 nm using a Beckman DU70 spectrophotometer. Controls containing all ingredients except the enoyl-CoAs were always run in parallel, and the control values were subtracted from the experimental ones.

2,4-dienoyl-CoA reductase activity was measured radiometrically as described by Nada et al. (13).

Purification of Enoyl-CoA Reductase from Peroxisomes-- Guinea pig liver peroxisomes, isolated as described (14), were suspended in 0.25 M sucrose, 10 mM TES, 1 mM EDTA buffer (pH 7.5) containing 0.1% Triton X-100 and protease inhibitors (1 µM leupeptin, 0.2 mM phenylmethylsulfonyl fluoride). The mixture was stirred for 30 min at room temperature and then centrifuged at 100,000 × g for 40 min. The enzyme from the pellet was solubilized in the above buffer containing also 1.0 M KCl and 0.3 mM NADPH. The mixture was centrifuged as above, and the supernatant was dialyzed overnight against a buffer (pH 7.4) containing 10 mM Tris, 2 mM dithiothreitol, 20% glycerol, 0.05% Triton X-100, and 0.2 M KCl. The dialyzed sample was centrifuged at 100,000 × g for 40 min to remove the precipitated acyl-DHAP reductase (7), and the supernatant was loaded onto a 2-ml agarose gel column containing bound NADP+ (4-5 µmol/ml) prepared as described previously (7). The column was washed with 12 ml (six fractions of 2 ml each) of the above dialyzing buffer, and then the enzyme was eluted from the column by using 12 ml (in 2-ml fractions) of the same buffer but also containing NADPH (2 mM).

SDS-PAGE Analysis-- SDS-PAGE and staining of the gel with Coomassie Blue G250 were as described before (15). Proteins from dilute samples were concentrated by trichloroacetic acid coprecipitation with carrier sodium deoxycholate (16) before electrophoresis. The precipitates were washed once with acetone to remove the trichloracetic acid, dissolved in 15 µl of sample buffer (0.1 M Tris-HCl, pH 6.8, 2% SDS, 20% beta -mercaptoethanol, 10% glycerol, and 0.02% bromphenol blue) by heating at 100 °C, and loaded on the gel.

Characterization of the Reaction Product by Argentation-Thin Layer Chromatography-- The AgNO3-containing thin layer chromatography plates were prepared by dipping the plates (Silica Gel 60; Merck) in a 30% AgNO3 solution in acetonitrile. After air-drying, the plates were activated by heating in an oven at 110 °C for 1 h, cooled, and used immediately. The 3H-labeled product formed by incubating 10:1 CoA and S-[4-3H]NADPH with the enzyme was converted to free fatty acids by hydrolysis as described above for the radiometric assay method. Fifty µg each of decanoic acid and trans-2-decenoic acid were added to the toluene extracts containing the labeled free acids, and the toluene was removed by blowing nitrogen. The fatty acids were converted to the methyl esters by treatment with 2,2'-dimethoxypropane-methanol-HCl as described previously (17). The methyl esters, along with the methyl ester standards were spotted on the AgNO3-impregnated plate, and the plate was developed with hexane/diethyl ether/acetic acid (70:30:1). In this system, the methyl ester of the trans-2-enoic fatty acids migrates at a slower rate (Rf = 0.56) than the corresponding methyl esters of saturated fatty acids (Rf = 0.64), as also described by Wood and Lee (18). The methyl ester spots on the TLC plate were visualized under UV light after spraying with Primuline (19) and scraped out, and the esters were extracted by chloroform-methanol (1:1) followed by removal of the solvents by blowing air. The amount of 3H in the extracts was quantified by liquid scintillation spectrometry.

Partial Amino Acid Sequencing-- Amino acid sequencing by Edman degradation was performed at the Protein Sequencing Facility of the University of Michigan. The partially purified enzyme was subjected to SDS-PAGE, the gel area corresponding to the 40-kDa band was excised and treated with CNBr (20), and the cleavage products were separated by SDS-PAGE followed by blotting on to a polyvinylidine difluoride membrane (Problott; Applied Biosystems). Two peptide bands from the blot, 3 and 6 kDa in size, were used directly for amino acid sequencing using an Applied Biosystems gas phase sequenator.

Screening Guinea Pig and Mouse Liver cDNA Libraries-- Total RNA from tissues was isolated by using an acidic CHCl3-phenol extraction method using the Trizol reagent (Life Technologies, Inc.) following the manufacturer's protocol and then further purified by CsCl density gradient centrifugation (21). A guinea pig liver cDNA library in Zap Express vector was made by Stratagene from the total RNA isolated from livers of adult animals. An adult mouse liver cDNA library cloned into lambda ZapII vector was purchased from Stratagene. The cDNA library screenings were done as described before (22). The filter paper blots of the colonies were hybridized with a mouse enoyl-CoA reductase cDNA probe labeled by using the random decamer priming method (Decaprime II; Ambion) and [alpha -32P]dATP. The template DNA used for making the 32P-probe was a 424-base pair (-45 to +378) mouse enoyl-CoA reductase cDNA fragment prepared by digestion of the plasmid isolated from a mouse EST clone (AA241896 Genome Systems) with EcoRI and SphI.

Expression and Purification of the Recombinant Proteins-- A DNA fragment containing the open reading frame of the guinea pig liver reductase cDNA in lambda Zap Express vector (clone 14) was excised by digestion with EcoRI and XhoI, purified by agarose gel electrophoresis (1.2-kb fragment), and then ligated into EcoRI- and XhoI-digested linearized 5.3-kb PET 28a(+) vector (Novagen) using T4 DNA ligase (Promega) in the presence of ATP. The resulting plasmid encodes a protein in which an amino-terminal His tag from the vector is fused in frame to the enoyl-CoA reductase coding sequence. The plasmid was introduced into competent BL-21 cells by heat-shock treatment according to the manufacturer's (Promega) instructions, and the transformed cells were selected for by utilizing their resistance to Kanamycin. The plasmid-containing bacteria were grown in LB broth with Kanamycin (40 µg/ml) at 37 °C to the mid-log phase (A600 = 0.3-0.4), IPTG (final concentration 0.5 mM) was then added, and the cells were allowed to grow for another 4-5 h. The cells were harvested by centrifugation and then lysed by treating with lysozyme (0.1 mg/ml) at pH 8.0 (50 mM Tris-HCl) in the presence of 0.1% Triton X-100 for 20 min at 30 °C. The mixture, cooled in ice, was sonicated two times for 10 s each using a probe sonicator (Branson). The sonicated mixture was centrifuged at 12,000 × g for 10 min, and the supernatant was collected. This supernatant was used both to measure the reductase activity and for the affinity purification of the recombinant His-tagged enzyme.

For the affinity purification of the recombinant enzyme, the bacterial extract (5-10 ml) in 20 mM Tris buffer (pH 8.0), 0.5 M NaCl, 5 mM imidazole, and 1.0 mM beta -mercaptoethanol (1.0 mM) was loaded onto a 2.5-ml Ni2+-nitrilotriacetic acid-agarose (Qiagen) column. The column was washed first with 10 volumes of the above binding buffer (wash 1) and further washed (wash 2) with six volumes of the same buffer but containing a higher concentration of imidazole (60 mM). The enzyme was eluted with six volumes of the buffer containing 0.3 M imidazole (elute 1), followed by elution with four volumes of 1.0 M imidazole (elute 2).

Raising Monoclonal Antibodies against the Reductase-- Monoclonal antibodies against the enoyl-CoA reductase were produced by the Hybridoma Core Facility (University of Michigan). The Balb/c mice were immunized against the partially purified enoyl-CoA reductase (see above), and their splenic cells were used to generate the hybridomas. The hybridomas were screened for antibody secretion by employing a dot blot enzyme-linked immunosorbent assay using the partially purified enzyme as the antigen. On that basis, six clones were selected and propagated as ascites cells in mice. One of the ascites fluid samples (isotype IgG1), which showed high specificity toward the enoyl-CoA reductase, was used in the Western blot analysis.

Western Blot Analysis of the Subcellular Fractions-- Subcellular fractionation of guinea pig liver to isolate major cellular organelles including peroxisomes and the assay of marker enzymes were done as described previously (14). The Western blot analysis was done by subjecting the subcellular fractions to SDS-PAGE (15), transferring the separated proteins to a polyvinylidene difluoride membrane, probing the blot with the monoclonal antibody, and then detecting the antibody-reacting protein bands using the Protoblot Western blot alkaline phosphatase system kit (Promega).

Northern Blotting-- Total RNA from guinea pig tissues was isolated and subjected to formaldehyde gel electrophoretic separation and transfer to Nytran membranes as described (21, 22). The mouse multiple tissue mRNA blot was from CLONTECH. The blots were hybridized with the radioactive mouse reductase cDNA probe prepared as described above. Blots were prehybridized for 30 min at 68 °C in Express Hyb (CLONTECH) and then hybridized for 60 min at 68 °C in Express Hyb containing the labeled probe (3-4 × 106 cpm/ml, 1-2 × 109 cpm/µg of template). The blots were washed three times at room temperature with a solution containing 2× SSC and 0.05% SDS, followed by two washes with 0.1× SSC and 0.1% SDS at 50 °C. The radioactivity on the blots was detected by autoradiography using Kodak X-Omat AR films.

All other materials and methods were the same as described previously (7, 22).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Assay of Enoyl-CoA Reductase-- Both spectrophotometric and radiometric methods were employed to assay the reductase. The enzyme activity was stimulated by the presence of bovine serum albumin in the incubation mixture (Table I). Table I also shows that NADPH cannot be replaced by NADH as a coenzyme. The product of the enzymatic reaction was identified as a saturated fatty acyl-CoA (see below). Although these two assay methods were qualitatively similar, lower activity (~50%) was seen with the radiometric assay (Table I), indicating an isotope effect when 3H-labeled NADPH was used as the reductant. However, because of high sensitivity and ease of assay, the radiometric method was employed when a large number of samples were to be assayed. The assay method used in other experiments is indicated in the legends of the figures and tables.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Comparison of assay systems
The incubation mixtures contained potassium phosphate buffer (50 mM), bovine serum albumin (2 mg/ml), either S-[4-3H]NADPH (70 µM) or NADPH (0.1 mM), guinea pig liver peroxisomes (10-40 µg of protein), and trans-2-enoyl CoA (30 µM) as indicated below. Concentration of NADH, when used, was 0.1 mM. The incubations and assays were done as described. The average (n = 3 or 4) specific activities along with their S.D. values are shown.

Partial Purification of the Peroxisomal Enzyme-- The enzyme is apparently bound to the peroxisomal membrane, because after osmotic shock of peroxisomes the enzyme activity remained associated with the membrane fraction (data not shown). A neutral detergent such as Triton X-100 in the presence of high concentrations of KCl or NaCl completely solubilized the enzyme. The enzyme, unlike acyl-DHAP reductase (7), remained soluble after the salt is dialyzed out. This solubilized enzyme was further purified by NADP affinity chromatography (Table II). When analyzed by SDS-PAGE, a 40-kDa protein band was found to be co-purified with the enzyme activity. This band was estimated to correspond to 40-60% of total proteins in different preparations. A typical SDS-PAGE analysis is shown in Fig. 1. Another major protein (60 kDa) that also binds to the affinity column, seen on the electrophoretogram (Fig. 1), was identified as catalase. Catalase has been shown to contain bound NADPH, although the physiological significance of the bound NADPH is unknown (23). The affinity-purified enzyme rapidly lost its activity upon storage, and attempts to further purify it were not successful.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Purification of peroxisomal trans-2-enoyl CoA reductase


View larger version (70K):
[in this window]
[in a new window]
 
Fig. 1.   SDS-PAGE of different fractions obtained during NADP affinity purification of the reductase. One to 5 µg of protein (except for lane 4, where 0.15 µg of protein was used) concentrated (see "Experimental Procedures") from the indicated column fractions (100-200 µl) were subjected to electrophoretic separation followed by Coomassie Blue staining. Lane 1, flow-through (200 µl); lane 2, first 2-ml wash (200 µl); lane 3, last 2-ml wash (200 µl); lane 4, 10 µl (without concentration) of the first 2 ml of the NADPH-eluted fraction; lane 5, same as lane 4, but 100 µl of the fraction (after concentration) was used; lanes 6-8, 200 µl each of the next three NADPH-eluted fractions. Lane 9, 0.5 µg of bovine serum albumin (66.2 kDa). Lane 10, protein molecular weight standards as shown. The arrowhead shows the 40-kDa band whose partial amino acid sequence was determined.

Partial Amino Acid Sequence of the 40-kDa Protein-- The 40-kDa protein band was resistant to Edman degradation, indicating that N-terminal amino acid of the protein is probably blocked. Therefore, after SDS-PAGE the protein band was treated with CNBr, and the resulting peptides were separated by another SDS-PAGE and blotted to a polyvinylidene difluoride membrane. The main bands on the blot were then subjected to Edman degradation. A 3-kDa fragment yielded the longest sequence (27 amino acids) as follows: KSTLALYGKIDFLVNNGGGQFWSSPEH.

Analysis of another fragment (6 kDa) yielded essentially the same partial amino acid sequence.

Cloning the cDNA of the Reductase-- Upon searching the GenBankTM data base, a number of human and mouse EST clones were identified whose DNA sequences coded (80-90% identity) for the above partial amino acid sequence. One of these mouse EST clones (AA241896) was used to generate a probe for screening a guinea pig liver cDNA library. A nucleotide sequence at the 5'-end of the clone, when translated, showed high (90%) amino acid identity with the first 21 residues of the guinea pig reductase partial amino acid sequence we determined. A 0.4-kb fragment containing this stretch of nucleotides was isolated and used as the template to generate 32P-labeled probe, which was then used to screen the library. A large number of positive clones were isolated in the screen, and the plasmids from two of these (clones 9 and 14) that contained the longest inserts (~1.4 kb) were subjected to nucleotide sequencing. Both of the strands of each insert were sequenced by the "primer-walking" method. The sequences obtained were identical except that the insert from clone 9 was missing 9 base pairs from the 5'-end compared with clone 14. The complete sequence (1380 base pairs) of clone 14 is shown in Fig. 2. An open reading frame was identified that started at ATG (+5) within the consensus Kozak (24) translation initiation sequence (GCCATGG) and coded for a polypeptide of 302 amino acids, which contained the same 27 amino acid sequence shown to be present in the peroxisomal 40-kDa protein (Fig. 2). The carboxyl-terminal tripeptide sequence (AKL) is a type 1 peroxisome-targeting signal (PTS-1) (25). The 0.5-kb 3'-untranslated region contained a noncanonical polyadenylation signal (AGTAAA) near the poly(A) tail (Fig. 2).


View larger version (59K):
[in this window]
[in a new window]
 
Fig. 2.   Nucleotide and deduced amino acid sequence of guinea pig liver cDNA encoding peroxisomal enoyl-CoA reductase. The underlined region corresponds to the determined partial amino acid sequence of the purified peroxisomal enzyme. The PTS-1 signal is boxed, and the subscript asterisks show the putative N-glycosylation signals. The polyadenylation signal is double underlined.

Cloning of the Mouse and Human cDNAs-- A similar screening of a mouse liver cDNA library using the same probe yielded a number of positive clones from which a homologous mouse cDNA sequence was assembled (GenbankTM accession no. AF232011). By analyzing a number of human EST clones that showed homology to the mouse and guinea pig cDNAs, we have identified a clone (AA232159) containing the full-length (1.9-kb) human reductase cDNA. This human cDNA sequence has also been submitted to the GenbankTM data base (accession no. AF232009). The three cDNA sequences have 3'-untranslated regions of varying chain lengths (0.3 kb for mouse, 0.5 kb for guinea pig, and 0.7 kb for human cDNAs), which do not show close homology with each other.

Translation of the putative open reading frames of these cDNAs shows that these polypeptides are highly homologous (71-75% identical and 90-93% similar) (Fig. 3), the guinea pig open reading frame being one amino acid shorter than the other two (303 amino acids). The calculated molecular masses of the guinea pig, mouse and human reductases are 32.5, 32.3, and 32.6 kDa, respectively. All of them have the PTS-1, AKL, at the carboxyl end. GenbankTM searches showed that these amino acid sequences are homologous to a large number of eukaryotic and prokaryotic pyridine nucleotide-linked dehydrogenases (see "Discussion").


View larger version (69K):
[in this window]
[in a new window]
 
Fig. 3.   Comparison of the deduced amino acid sequences of peroxisomal enoyl-CoA reductase from guinea pig, mouse, rat, and human.

Fig. 3 also shows the comparison of a putative amino acid sequence of a rat cDNA sequence that is highly homologous to the enoyl-CoA reductase protein sequences in other species, especially mouse (86% identical, 97% similar). This sequence has been submitted to GenBankTM with a tentative identification as either short chain acyl dehydrogenase (AF099742) or peroxisomal 2,4-dienoyl-CoA reductase (AF021854). The main difference between the rat protein and that of the other species is that ARL is the carboxyl-terminal tripeptide sequence for the rat protein instead of AKL for the other three. ARL is not a common mammalian PTS-1, but it is known to be a PTS-1 for S. cerevisiae proteins (25).

Expression and Purification of the Active Recombinant 2-Enoyl-CoA Reductase-- The full-length guinea pig liver cDNA was subcloned into a T7lac promoter-containing expression vector (Pet 28a), which was then used to transform E. coli cells as described under "Experimental Procedures." The transformed cells expressed a protein having high 2-enoyl-CoA reductase activity when the T7lac inducer IPTG was added to the growing transformed cells in culture (data not shown). As expected, the recombinant fusion protein, containing six consecutive His residues at the N terminus, binds tightly to a Ni2+-chelate affinity resin and can be quantitatively eluted by imidazole-containing buffer (Fig. 4A). The recombinant reductase, purified 50-fold from the crude extract, had a specific activity of 1700 nmol/min/mg of protein (spectrophotometric assay). Upon SDS-PAGE, the purified enzyme showed a single 43-kDa band (Fig. 4B). The calculated molecular mass of the recombinant reductase is, however, 36.7 kDa. The purified enzyme is unstable toward storage at 4 °C or -70 °C but is somewhat stabilized by thiols such as beta -mercaptoethanol or dithiothreitol. The half-life of the enzyme in the presence of 1 mM dithiothreitol is about 5 days at 4 °C. The purified enzyme completely lost its activity on freezing and thawing.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 4.   A, affinity purification of the recombinant enzyme. The E. coli expressing the reductase cDNA was grown (250-ml culture) in the presence of IPTG as described under "Experimental Procedures." Six h after the addition of IPTG, the cells were harvested by centrifugation and stored frozen at -20 °C overnight. The cells were thawed, and the recombinant enzyme was extracted (7 ml, 875 milliunits total) from the cells and then purified by affinity chromatography (2.5 ml Ni2+-nitrilotriacetic acid matrix) as described under "Experimental Procedures." FT, flow-through (7 ml); Wash 1, 25 ml of buffer containing 5 mM imidazole; Wash 2, 15 ml of buffer containing 60 mM imidazole; Elute 1, 15 ml of buffer containing 0.3 M imidazole; Elute 2, 10 ml of buffer containing 1.0 M imidazole. The total activity of reductase present in each fraction is shown. B, SDS-PAGE analysis of the column fractions. Twelve µl of each fraction was used for electrophoresis. Lane 1, flow-through; lane 2, wash 1 (5 mM imidazole); lane 3, wash 2 (60 mM imidazole); lane 4, elute 1 (0.3 M imidazole); lane 5, elute 2 (1.0 M imidazole); lane 6, crude E. coli cell extract that was loaded to the column; lane 7, partially purified guinea pig liver peroxisomal enoyl-CoA reductase (solubilized fraction, Table II); lane 8, protein molecular weight standards as indicated.

The human recombinant His-tagged enzyme was also similarly expressed and affinity-purified. The properties of the human reductase are similar to those described for the guinea pig recombinant enzyme (data not shown).

Properties of the Recombinant Reductase-- The properties of the guinea pig recombinant reductase are similar to those of the peroxisomal enzyme as evidenced by its specificity toward using NADPH as the coenzyme and inhibition by the thiol-reactive reagent, N-ethylmaleimide (Table III). In a spectrophotometric assay, the recombinant enzyme, like the peroxisomal enzyme (Table I), was found not to use NADH as the coenzyme (data not shown). Unlike liver peroxisomes, the purified recombinant enzyme did not have any 2,4-dienoyl-CoA reductase activity (Table III). This indicates that the peroxisomal 2,4-dienoyl-CoA reductase is an enzyme distinct from the peroxisomal enoyl-CoA reductase whose cDNA we cloned. Both the recombinant and liver peroxisomal enzymes are inhibited by higher concentrations (>50 µM) of decenoyl-CoA (data not shown). The apparent Km values for decenoyl-CoA were 11 and 18 µM for the peroxisomal and the recombinant enzymes, respectively. The corresponding Km values for NADPH were 38 and 53 µM. The substrate specificity of both the peroxisomal and the recombinant enzymes toward different enoyl-CoAs is similar (except for 6:1) with maximum activity against 10:1 CoA, and the specificity is different from that of guinea pig liver microsomal reductase (Fig. 5). As reported previously (26), it is also seen here that the microsomal reductase has the highest activity with 2-hexenoyl-CoA (Fig. 5). The relatively higher activity of the peroxisomal enzyme with 6:1 CoA compared with the recombinant enzyme is probably due to microsomal contamination (~10%) of the peroxisome preparation.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Inhibition and specificity of peroxisomal and recombinant enzymes
The assay mixtures contained phosphate buffer (50 mM, pH 7.4), S-[4-3H]NADPH (70 µM, 8000 dpm/nmol), peroxisomes (10-40 µg of protein) or purified recombinant enzyme (0.5-2.0 µg of protein), and acyl-CoAs (30 µM) as indicated. Bovine serum albumin (2 mg/ml) was also included for the 2-enoyl reductase assay. For the N-ethylmaleimide (NEM) inhibition studies, the enzyme in 0.1 M phosphate buffer was preincubated with N-ethylmaleimide (1.0 mM) for 5 min at 37 °C, and aliquots were used for the assay. The results presented are the average of four radiometric assays.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 5.   Chain length specificity of guinea pig liver microsomal (MS), peroxisomal (PX), and the purified recombinant enzyme (RE). The rate of reduction of different enoyl-CoAs (40 µM) having different chain lengths by S-[4-3H]NADPH (70 µM) catalyzed by the reductase from different sources was determined radiometrically as described under "Experimental Procedures." The results are presented as the percentage of maximum activity, which was 10.5 milliunits/mg of protein for microsomes with 6:1 CoA, 4.1 milliunits/mg of protein for peroxisomes with 10:1 CoA, and 860 milliunits/mg of protein for the purified recombinant reductase with 10:1 CoA.

Identification of the Enzymatic Reaction Product-- The product of the reaction between 2-decenoyl-CoA and 4-[3H]NADPH, catalyzed either by peroxisomes or purified recombinant enzyme, was identified as [3H]decanoyl-CoA. This was done by converting the labeled reaction product to methyl ester, which was then cochromatographed with methyl 2-decenoate and methyl decanoate on a silver nitrate-coated TLC plate (see "Experimental Procedures"). All of the radioactivity migrated with the faster moving methyl decanoate (Rf = 0.64) and not with the methyl decenoate (Rf = 0.56), indicating that the double bond of the 2-decenoyl-CoA is reduced by NADPH to a saturated acyl-CoA.

Peroxisomal Localization of the Cloned Reductase-- The purification of the enzyme from isolated guinea pig liver peroxisomes and the presence of a PTS-1 in the amino acid sequence of the enzyme indicate that the cloned reductase is a peroxisomal enzyme. This is confirmed by Western blot analysis using a monoclonal antibody raised against the purified enzyme. Although, in addition to peroxisomal activity, enoyl-CoA reductase activity is also present in mitochondria and at a higher concentration in the ER (microsomes), the monoclonal antibody raised against the partially purified enzyme interacted specifically with the peroxisomal fraction (Fig. 6). The weak positive signal seen in mitochondrial and microsomal fractions is probably due to the presence of contaminating peroxisomes in these fractions, as evidenced by the activity of peroxisome membrane-specific DHAP acyltransferase in these fractions (Fig. 6). The specificity of the antibody used for the cloned enzyme is also seen in Fig. 6 by its interaction with the recombinant reductase. As indicated above, because of the presence of additional amino acids, including the His tag at the N terminus of the recombinant enzyme, the molecular mass of the recombinant enzyme is greater (by about 4 kDa) than that of the native enzyme.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 6.   Western blot analysis of the distribution of the cloned enoyl-CoA reductase in guinea pig liver subcellular fractions. The subcellular fractionations, assays of different enzymes, and Western blotting were done as described under "Experimental Procedures." The distribution of the enoyl-CoA reductase activity (top panel) in the major subcellular fractions and Western blot analysis (bottom panel) of the same fractions are shown along with the distribution of organelle-marker enzymes. S-1, postnuclear supernatant; MT, mitochondria (marker enzyme, succinate-cytochrome c reductase); PX, peroxisomes (marker enzyme, DHAP acyltransferase measured at pH 5.5); MS, microsomes (marker enzyme, ER-specific NADPH-cytochrome c reductase); Cyt, cytosol; rRed, recombinant His-tagged enoyl-CoA reductase; STD, protein molecular mass standard (42-kDa protein band is shown by the arrowhead). The specific activities of different enzymes in each subcellular fraction are shown (top four panels). The amounts of protein used in the SDS-PAGE for the Western analysis as shown in the bottom panel were 1.5 µg for postnuclear supernatant; 0.2 µg each for mitochondria, peroxisomes, and microsomes; and 0.03 µg for the purified (Fig. 4) recombinant reductase.

Northern Blot Analysis-- When a mouse multitissue RNA blot was hybridized with the 32P-labeled mouse DNA probe as described above, a single radioactive band of ~1.3 kb was seen with greatest intensities in liver and kidney and at lower levels in heart, skeletal muscle, and other tissues (Fig. 7). Hybridization of a guinea pig tissue RNA blot with the same 32P-probe showed a single transcript of 1.5 kb present not only in liver and kidney but also in other tissues in much lower concentrations (data not shown).


View larger version (47K):
[in this window]
[in a new window]
 
Fig. 7.   Northern blot analysis. The mouse multitissue poly(A)+ RNA (2 µg each) blot (CLONTECH) was hybridized with a 32P-labeled reductase cDNA probe, washed, and autoradiographed as described under "Experimental Procedures." The upper panel shows the autoradiogram after overnight exposure, and the lower panel shows the autoradiogram of the same blot (1.3-kilobase region) after longer exposure (5 days) to the x-ray film. The mobilities of the size markers and the tissues used (Muscle represents skeletal muscle) are shown.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The induction of the active 2-enoyl-CoA reductase when the cDNAs were expressed in E. coli and the similarity of the properties and specificity of the purified recombinant enzyme with those of the peroxisomal enzyme, but not with the microsomal reductase, show that the cloned cDNAs encode a peroxisomal trans-2-enoyl-CoA reductase. The presence of the PTS-1 in the protein sequences and Western analysis of its subcellular distribution (Fig. 6) corroborate the peroxisomal location of the reductase. These results also confirm the report by Horie et al. (6), which provided good evidence for the presence of an enoyl-CoA reductase in rat liver peroxisomes. The reaction catalyzed by this reductase is shown below (Scheme 1).
<UP>R–CH<SUB>2</SUB>–</UP><AR><R><C><UP>3</UP></C></R><R><C><UP>C</UP></C></R><R><C> </C></R></AR><UP>H&z.dbnd6;</UP><AR><R><C><UP>2</UP></C></R><R><C><UP>C</UP></C></R><R><C> </C></R></AR><UP>H–</UP><AR><R><C> </C></R><R><C><UP>1</UP></C></R><R><C><UP>C</UP></C></R><R><C><UP>∥</UP></C></R><R><C><UP>O</UP></C></R></AR>∼<UP>SCoA</UP>+<UP>NADPH</UP>+<UP>H<SUP>+</SUP></UP>

<UP>→ R–CH<SUB>2</SUB>–</UP><AR><R><C><UP>3</UP></C></R><R><C><UP>C</UP></C></R><R><C> </C></R></AR><UP>H<SUB>2</SUB>–</UP><AR><R><C><UP>2</UP></C></R><R><C><UP>C</UP></C></R><R><C> </C></R></AR><UP>H<SUB>2</SUB>–</UP><AR><R><C> </C></R><R><C><UP>1</UP></C></R><R><C><UP>C</UP></C></R><R><C><UP>∥</UP></C></R><R><C><UP>O</UP></C></R></AR>∼<UP>SCoA</UP>+<UP>NADP<SUP>+</SUP></UP>

<UP><SC>Scheme</SC> 1</UP>
As indicated above, the putative amino acid sequences of the reductase (Fig. 3) have high homology to a large number of pyridine nucleotide-linked dehydrogenases. These polypeptide sequences seem to belong to the recently described "short chain acyl dehydrogenase/reductase" family (27). For example, the N-terminal part of the consensus sequence of the reductase has the same NAD(P)H-binding motif, GXXXGXG, at amino acid residues 25-31 (Fig. 3). Similarly, the YX3-7K motif shown to be present in the catalytic center of such dehydrogenases is also present in the enoyl-CoA reductase at residues 179-183 (178-182 for the guinea pig enzyme). The amino acid sequences of the enoyl-CoA reductase (Fig. 3) have hydrophobic stretches (e.g. from residue 153 to 162 and from 242 to 251), but none of them meet the criteria for a membrane-spanning alpha -helical structure. Interestingly, there are two conserved N-glycosylation motifs (NLT) at positions 131 and 180 (179 for the guinea pig) of the amino acid sequences. Although to date no peroxisomal proteins have been shown to be N-glycosylated (28), recently Elgersma et al. provided evidence that Pex 15P, an S. cerevisiae peroxisomal membrane protein, is O-glycosylated (29).

Among the mammalian dehydrogenases, the enoyl-CoA reductase has high homology to both mitochondrial (31% identity, 51% similarity) and peroxisomal (31% identity, 49% similarity) 2,4-dienoyl-CoA reductase (30, 31). The peroxisomal enoyl-CoA reductases also have homology to the bacterial enoyl-ACP reductases that catalyze the same reaction (22% identity and 50% similarity extending throughout the protein sequence of the E. coli enzyme). Surprisingly, the reductase sequences (Fig. 3) have only very limited homology to the enoyl reductase domain of the multifunctional mammalian fatty acid synthase (32, 33). This indicates that the enoyl reductases described here belong to a new family of enzymes and may have counterparts in the ER and mitochondria of mammalian cells. Therefore, the availability of these cDNA clones will aid in the discovery of other cellular isoenzymes, and the active recombinant enzyme will facilitate studies into the structure of the enzyme and the molecular details of the catalytic mechanism for the reduction of the double bond.

As discussed above, one rat cDNA recently submitted to GenBankTM (AF021854 and AF099742) from two different laboratories has very high homology to the cloned cDNAs reported here, indicating that it is most probably the rat counterpart of peroxisomal enoyl-CoA reductase. Although AF021854 was tentatively designated as coding for 2,4-dienoyl-CoA reductase, we did not find any such activity in the recombinant guinea pig enzyme. While this manuscript was in preparation, the details of cloning of the AF099742 were described by Zhang and Underwood (34). These authors isolated the clone from fasted rat liver cDNA library prepared by "suppression subtractive hybridization." Although the enzyme it coded was not identified, they also pointed out the homology of the sequence to short chain acyl dehydrogenase/reductase family and the presence of PTS-1 in the putative polypeptide. Consistent with our results, transcript levels were found to be highest in rat liver and kidney, and it has been also shown that the liver transcript level is increased when the rats are fasted for 48 h. Sequence homology, as shown in Fig. 3, strongly suggests that this cDNA encodes the rat peroxisomal 2-enoyl-CoA reductase.

Although the partially purified peroxisomal enzyme seemed to be about 40-60% pure, it had a much lower specific activity (75 milliunits/mg of protein by radiometric assay) than the purified recombinant enzyme (600-750 milliunits/mg of protein). This is probably because the enzyme became very labile after the detergent solubilization but a significant fraction of the partially denatured enzyme still was capable of binding to the NADP+ affinity matrix. The purified recombinant enzyme had up to 2.0 units/mg of protein activity by the spectrophotometric assay, which is ~200 times the specific activity of the liver peroxisomal reductase. The expression of an active recombinant enzyme in E. coli shows that post-translational modifications (e.g. glycosylation) are not necessary for enzyme activity.

The substrate specificity of the enzyme shows that it may be termed a medium chain enoyl-CoA reductase, with specificity similar to that of mitochondrial and microsomal reductases. However, the longer chain enoyl-CoAs (14:1 and 16:1) are also good substrates for both the microsomal and the peroxisomal enzymes (Fig. 7), indicating that this enzyme may have a similar function in both of these organelles. Horie et al. (6) showed that in peroxisomes, octanoyl-CoA is chain-elongated to form dodecanoyl-CoA, and recently, Hayashi and Sato (35) demonstrated that in rat liver peroxisomes dodecanoyl-CoA was chain-elongated to form palmitoyl-CoA, which was reduced to hexadecanol by the NADPH-linked peroxisomal acyl-CoA reductase (36). These results show that fatty acid chain elongation in peroxisomes can be demonstrated in vitro. The physiological importance of the peroxisomal chain elongation system, however, is not clear. Although the specific activity of the peroxisomal enoyl-CoA reductase, the key enzyme for the fatty acid chain elongation system, is similar to that of the ER enzyme, the total activity of cellular ER reductase is much more than the peroxisomal enzyme, because the ER contains about 10 times more protein than peroxisomes per cell (37). Therefore, it seems that the ER is the main cellular site for chain elongation of fatty acids.

There is also a dilemma concerning the peroxisomal and also mitochondrial elongation systems because a highly active fatty acid beta -oxidation system is also present in the these organelles. It is not clear how these two opposing metabolic pathways could be regulated without compartmentalization. It is possible that the peroxisomal enoyl-CoA reductase may have some functions other than participating in the fatty acid chain elongation system. For example, this reductase may be involved in the reduction of cis-double bonds at even-numbered carbons of unsaturated fatty acids. It has been shown that in mitochondria these fatty acids are mainly metabolized via their conversion to 2,4-dienoyl-CoA followed by reduction (NADPH) to 3-enoyl-CoA, which is then isomerized to trans-2-enoyl-CoA (38). trans-2-Enoyl-CoA is either further metabolized by beta -oxidation or is reduced by NADPH-linked 2-enoyl-CoA reductase. The presence of 2,4-dienoyl-CoA reductase, Delta 3,Delta 2-enoyl-CoA isomerase (38), and also, as shown here, enoyl-CoA reductase in peroxisomes indicates that a similar conversion of cis-double bonds may occur in peroxisomes. Recent findings show that unsaturated fatty acids having double bond(s) at the odd-numbered carbon atoms are also not oxidized directly in the beta -oxidation pathway but are converted to medium chain 2-enoyl-CoAs via a reductive pathway (39, 40). The key enzyme for such conversion, i.e. Delta 3,5,Delta 2,4-dienoyl-CoA isomerase, has been shown to be present in both liver mitochondria and peroxisomes (41). Because medium chain acyl-CoAs are not the substrates for peroxisomal beta -oxidation, the peroxisomal enoyl-CoA reductase could catalyze the reduction of the medium chain enoyl-CoAs formed via these reductive pathways to the saturated acyl-CoAs, which may then be converted to the carnitine derivatives and exported to mitochondria for oxidation and energy production. This pathway is probably physiologically important for the complete oxidation of unsaturated fatty acids in liver, especially when the metabolism is switched from utilizing glucose to utilizing fatty acids in conditions such as starvation or an acute diabetic state (42, 43). Therefore, the present report of cloning the enoyl-CoA reductase cDNAs will not only facilitate cloning of the cDNAs of other cellular isoforms of this key enzyme of fatty acid metabolism and study of the structure-function relationship of the enzyme but also will be useful for understanding the mechanism of regulation of fatty acid metabolism in different physiological and pathological conditions.

    ACKNOWLEDGEMENTS

We thank Dr. Shuichi Horie for the generous gift of different 2-enoic acids and Karen Hajra for invaluable assistance and editorial advice in the preparation of the manuscript.

    FOOTNOTES

* This work was supported by National Institutes of Health Grant NS 15747.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF232009, AF232010, and AF232011.

Dagger To whom correspondence should be addressed: Neuroscience Laboratory, University of Michigan, 1103 E. Huron St., Ann Arbor, MI 48104-1687. Tel.: 734-763-4368; Fax: 734-936-2690; E-mail: akhajra@umich.edu.

Published, JBC Papers in Press, May 11, 2000, DOI 10.1074/jbc.M001168200

    ABBREVIATIONS

The abbreviations used are: ER, endoplasmic reticulum; DHAP, dihydroxyacetone phosphate; IPTG, isopropyl beta -D-thiogalactopyranoside; EST, expressed sequence tag; TES, 2-{[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino}ethanesulfonic acid; PAGE, polyacrylamide gel electrophoresis; kb, kilobase pair(s); PTS-1, type 1 peroxisome-targeting signal.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Cinti, D. L., Cook, L., Nagi, M. N., and Suneja, S. K. (1992) Progr. Lipid Res. 31, 1-51
2. Sprecher, H., Luthria, D. L., Mohammed, B. S., and Baykousheva, S. P. (1995) J. Lipid Res. 36, 2471-2477
3. Seubert, W., and Podack, E. R. (1973) Mol. Cell. Biochem. 1, 29-40
4. Cvetanovic, M., Moreno de la Garza, M., Dommes, V., and Kunau, W. H. (1985) Biochem. J. 227, 9-56
5. Nagi, M. N., Cook, L., Ghesquier, D., and Cinti, D. L. (1986) Arch. Biochem. Biophys. 248, 408-418
6. Horie, S., Suzuki, T., and Suga, T. (1989) Arch. Biochem. Biophys. 274, 64-73
7. Datta, S. C., Ghosh, M. K., and Hajra, A. K. (1990) J. Biol. Chem. 265, 8268-8274
8. Lauer, W. M., Gensler, W. J., and Miller, E. (1941) J. Am. Chem. Soc. 63, 1153-1155
9. Thomason, S. C., and Kubler, D. G. (1968) J. Chem. Educ. 45, 546-547
10. Hajra, A. K., and Bishop, J. E. (1986) Methods Enzymol. 122, 50-53
11. Stadtman, E. R. (1957) Methods Enzymol. 3, 931-941
12. Ellman, G. L. (1959) Arch. Biochem. Biophys. 82, 70-77
13. Nada, M. A., Roe, C. R., and Schulz, H. (1992) Anal. Biochem. 201, 62-67
14. Hajra, A. K., Larkins, L. K., and Reddy, J. K. (1998) in Cell: A Laboratory Manual (Spector, D. L. , Leinwand, L. , and Goldman, R., eds) , pp. 40.1-40.12, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
15. Broustas, C. G., and Hajra, A. K. (1995) J. Neurochem. 64, 2345-2353
16. Bensadoun, A., and Weinstein, D. (1976) Anal. Biochem. 70, 241-250
17. Radin, N. S., Hajra, A. K., and Akahori, Y. (1960) J. Lipid Res. 1, 250-251
18. Wood, R., and Lee, T. (1981) J. Biol. Chem. 256, 12379-12386
19. Wright, R. S. (1971) J. Chromatogr. 59, 220-221
20. Matsudaira, P. (1990) Methods Enzymol. 182, 602-613
21. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , pp. 7.19-7.52, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
22. Broustas, C. G., Larkins, L. K., Uhler, M. D., and Hajra, A. K. (1996) J. Biol. Chem. 271, 10470-10476
23. Kirkman, H. N., and Gaetani, G. F. (1984) Proc. Natl. Acad. Sci. U. S. A. 81, 4343-4347
24. Kozak, M. (1992) Annu. Rev. Cell Biol. 8, 197-225
25. Subramani, S. (1998) Physiol. Rev. 78, 171-188
26. Podack, E. R, Lakomek, M., Saathoff, G., and Seubert, W. (1974) Eur. J. Biochem. 45, 13-23
27. Jornvall, H., Persson, B., Krook, M., Atrian, S., Gonzalez-Duarte, R., Jeffery, J., and Ghosh, D. (1995) Biochemistry 34, 6003-6013
28. Volkl, A., and Lazarow, P. B. (1982) Ann. N. Y. Acad. Sci. 386, 504-505
29. Elgersma, Y., Kwast, L., van den Berg, M., Snyder, W. B., Distel, B., Subramani, S., and Tabak, H. F. (1997) EMBO J. 16, 7326-7341
30. Fransen, M., Van Veldhoven, P. P., and Subramani, S. (1999) Biochem. J. 340, 561-568
31. Geisbrecht, B. V., Liang, X., Morrell, J. C., Schulz, H., and Gould, S. J. (1999) J. Biol. Chem. 274, 25814-25820
32. Witkowski, A., Rangan, V. S., Randhawa, Z. I., Amy, C. M., and Smith, S. (1991) Eur. J. Biochem. 198, 571-579
33. Chirala, S. S., Huang, W. Y., Jayakumar, A., Sakai, K., and Wakil, SJ (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 5588-5893
34. Zhang, J., and Underwood, L. E. (1999) Biochim. Biophys. Acta 1435, 184-190
35. Hayashi, H., and Sato, A. (1997) Biochim. Biophys. Acta 1346, 38-44
36. Burdett, K., Larkins, L. K., Das, A. K., and Hajra, A. K. (1991) J. Biol. Chem. 266, 12201-12206
37. De Duve, C. (1971) J. Cell Biol. 50, 20d-55d
38. Kunau, W. H., Dommes, V., and Schulz, H. (1995) Progr. Lipid Res. 34, 267-342
39. Tserng, K. Y., Jin, S. J., and Chen, L. S. (1996) Biochem. J. 313, 581-588
40. Shoukry, K., and Schulz, H. (1998) J. Biol. Chem. 273, 6892-6899
41. He, X. Y., Shoukry, K., Chu, C., Yang, J., Sprecher, H., and Schulz, H. (1995) Biochem. Biophys. Res. Commun. 215, 15-22
42. Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., and Wahli, W. (1999) J. Clin. Invest. 103, 1489-1498
43. Kroetz, D. L., Yook, P., Costet, P., Bianchi, P., and Pineau, T. (1998) J. Biol. Chem. 273, 31581-31589


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
A. Bye, M. A. Hoydal, D. Catalucci, M. Langaas, O. J. Kemi, V. Beisvag, L. G. Koch, S. L. Britton, O. Ellingsen, and U. Wisloff
Gene expression profiling of skeletal muscle in exercise-trained and sedentary rats with inborn high and low VO2max
Physiol Genomics, November 1, 2008; 35(3): 213 - 221.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. Gloerich, D. M. van den Brink, J. P. N. Ruiter, N. van Vlies, F. M. Vaz, R. J. A. Wanders, and S. Ferdinandusse
Metabolism of phytol to phytanic acid in the mouse, and the role of PPAR{alpha} in its regulation
J. Lipid Res., January 1, 2007; 48(1): 77 - 85.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. M. van den Brink, J. N. I. van Miert, G. Dacremont, J.-F. Rontani, and R. J. A. Wanders
Characterization of the Final Step in the Conversion of Phytol into Phytanic Acid
J. Biol. Chem., July 22, 2005; 280(29): 26838 - 26844.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Hoffmeister, M. Piotrowski, U. Nowitzki, and W. Martin
Mitochondrial trans-2-Enoyl-CoA Reductase of Wax Ester Fermentation from Euglena gracilis Defines a New Family of Enzymes Involved in Lipid Synthesis
J. Biol. Che